Global Sickle Cell Disease Treatments Market Growth (Status and Outlook) 2018-2023

Report ID: f80d841c0cd8 Category: Pages: 131 LPI(LP Information) 10/22/2018

$3,660$7,320

Clear

Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person’s parents.
The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication.
Over the next five years, LPI(LP Information) projects that Sickle Cell Disease Treatments will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Sickle Cell Disease Treatments market for 2018-2023.

This report presents a comprehensive overview, market shares and growth opportunities of Sickle Cell Disease Treatments market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
Infection Prevention with Vaccination and Antibiotics
Blood Transfusion
A Transplant of Bone Marrow Cells
Segmentation by application:
Hospitals
Ambulatory Surgical Centers
Clinics
Others

We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird Bio
Global Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Sickle Cell Disease Treatments market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Sickle Cell Disease Treatments market by identifying its various subsegments.
Focuses on the key global Sickle Cell Disease Treatments players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Sickle Cell Disease Treatments with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Sickle Cell Disease Treatments submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Report ID: f80d841c0cd8 Category: Pages: 131 LPI(LP Information) 10/22/2018

Table of Contents

2018-2023 Global Sickle Cell Disease Treatments Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sickle Cell Disease Treatments Market Size 2013-2023
2.1.2 Sickle Cell Disease Treatments Market Size CAGR by Region
2.2 Sickle Cell Disease Treatments Segment by Type
2.2.1 Infection Prevention with Vaccination and Antibiotics
2.2.2 Blood Transfusion
2.2.3 The Medication Hydroxycarbamide
2.2.4 A Transplant of Bone Marrow Cells
2.3 Sickle Cell Disease Treatments Market Size by Type
2.3.1 Global Sickle Cell Disease Treatments Market Size Market Share by Type (2013-2018)
2.3.2 Global Sickle Cell Disease Treatments Market Size Growth Rate by Type (2013-2018)
2.4 Sickle Cell Disease Treatments Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Clinics
2.4.4 Others
2.5 Sickle Cell Disease Treatments Market Size by Application
2.5.1 Global Sickle Cell Disease Treatments Market Size Market Share by Application (2013-2018)
2.5.2 Global Sickle Cell Disease Treatments Market Size Growth Rate by Application (2013-2018)

3 Global Sickle Cell Disease Treatments by Players
3.1 Global Sickle Cell Disease Treatments Market Size Market Share by Players
3.1.1 Global Sickle Cell Disease Treatments Market Size by Players (2016-2018)
3.1.2 Global Sickle Cell Disease Treatments Market Size Market Share by Players (2016-2018)
3.2 Global Sickle Cell Disease Treatments Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Sickle Cell Disease Treatments by Regions
4.1 Sickle Cell Disease Treatments Market Size by Regions
4.2 Americas Sickle Cell Disease Treatments Market Size Growth
4.3 APAC Sickle Cell Disease Treatments Market Size Growth
4.4 Europe Sickle Cell Disease Treatments Market Size Growth
4.5 Middle East & Africa Sickle Cell Disease Treatments Market Size Growth

5 Americas
5.1 Americas Sickle Cell Disease Treatments Market Size by Countries
5.2 Americas Sickle Cell Disease Treatments Market Size by Type
5.3 Americas Sickle Cell Disease Treatments Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Sickle Cell Disease Treatments Market Size by Countries
6.2 APAC Sickle Cell Disease Treatments Market Size by Type
6.3 APAC Sickle Cell Disease Treatments Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Sickle Cell Disease Treatments by Countries
7.2 Europe Sickle Cell Disease Treatments Market Size by Type
7.3 Europe Sickle Cell Disease Treatments Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Sickle Cell Disease Treatments by Countries
8.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type
8.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Sickle Cell Disease Treatments Market Forecast
10.1 Global Sickle Cell Disease Treatments Market Size Forecast (2018-2023)
10.2 Global Sickle Cell Disease Treatments Forecast by Regions
10.2.1 Global Sickle Cell Disease Treatments Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Sickle Cell Disease Treatments Forecast by Type
10.8 Global Sickle Cell Disease Treatments Forecast by Application

11 Key Players Analysis
11.1 AstraZeneca
11.1.1 Company Details
11.1.2 Sickle Cell Disease Treatments Product Offered
11.1.3 AstraZeneca Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 AstraZeneca News
11.2 Eli Lilly
11.2.1 Company Details
11.2.2 Sickle Cell Disease Treatments Product Offered
11.2.3 Eli Lilly Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Eli Lilly News
11.3 Bristol-Myers Squibb
11.3.1 Company Details
11.3.2 Sickle Cell Disease Treatments Product Offered
11.3.3 Bristol-Myers Squibb Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Bristol-Myers Squibb News
11.4 Novartis
11.4.1 Company Details
11.4.2 Sickle Cell Disease Treatments Product Offered
11.4.3 Novartis Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Novartis News
11.5 Pfizer
11.5.1 Company Details
11.5.2 Sickle Cell Disease Treatments Product Offered
11.5.3 Pfizer Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Pfizer News
11.6 Baxter
11.6.1 Company Details
11.6.2 Sickle Cell Disease Treatments Product Offered
11.6.3 Baxter Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Baxter News
11.7 Emmaus Life Sciences
11.7.1 Company Details
11.7.2 Sickle Cell Disease Treatments Product Offered
11.7.3 Emmaus Life Sciences Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Emmaus Life Sciences News
11.8 Bluebird Bio
11.8.1 Company Details
11.8.2 Sickle Cell Disease Treatments Product Offered
11.8.3 Bluebird Bio Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Bluebird Bio News
11.9 Global Blood Therapeutics
11.9.1 Company Details
11.9.2 Sickle Cell Disease Treatments Product Offered
11.9.3 Global Blood Therapeutics Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Global Blood Therapeutics News
11.10 Sangamo Therapeutics
11.10.1 Company Details
11.10.2 Sickle Cell Disease Treatments Product Offered
11.10.3 Sangamo Therapeutics Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Sangamo Therapeutics News
11.11 Acceleron Pharma
11.12 Arena Pharmaceuticals
11.13 Alnylam Pharmaceuticals

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Sickle Cell Disease Treatments
Figure Sickle Cell Disease Treatments Report Years Considered
Figure Market Research Methodology
Figure Global Sickle Cell Disease Treatments Market Size Growth Rate 2013-2023 ($ Millions)
Table Sickle Cell Disease Treatments Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Infection Prevention with Vaccination and Antibiotics
Table Major Players of Blood Transfusion
Table Major Players of The Medication Hydroxycarbamide
Table Major Players of A Transplant of Bone Marrow Cells
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size Market Share by Type (2013-2018)
Figure Global Sickle Cell Disease Treatments Market Size Market Share by Type (2013-2018)
Figure Global Infection Prevention with Vaccination and Antibiotics Market Size Growth Rate
Figure Global Blood Transfusion Market Size Growth Rate
Figure Global The Medication Hydroxycarbamide Market Size Growth Rate
Figure Global A Transplant of Bone Marrow Cells Market Size Growth Rate
Figure Sickle Cell Disease Treatments Consumed in Hospitals
Figure Global Sickle Cell Disease Treatments Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Sickle Cell Disease Treatments Consumed in Ambulatory Surgical Centers
Figure Global Sickle Cell Disease Treatments Market: Ambulatory Surgical Centers (2013-2018) ($ Millions)
Figure Global Ambulatory Surgical Centers YoY Growth ($ Millions)
Figure Sickle Cell Disease Treatments Consumed in Clinics
Figure Global Sickle Cell Disease Treatments Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Sickle Cell Disease Treatments Consumed in Others
Figure Global Sickle Cell Disease Treatments Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size by Application (2013-2018) ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size Market Share by Application (2013-2018)
Figure Global Sickle Cell Disease Treatments Market Size Market Share by Application (2013-2018)
Figure Global Sickle Cell Disease Treatments Market Size in Hospitals Growth Rate
Figure Global Sickle Cell Disease Treatments Market Size in Ambulatory Surgical Centers Growth Rate
Figure Global Sickle Cell Disease Treatments Market Size in Clinics Growth Rate
Figure Global Sickle Cell Disease Treatments Market Size in Others Growth Rate
Table Global Sickle Cell Disease Treatments Revenue by Players (2016-2018) ($ Millions)
Table Global Sickle Cell Disease Treatments Revenue Market Share by Players (2016-2018)
Figure Global Sickle Cell Disease Treatments Revenue Market Share by Players in 2017
Table Global Sickle Cell Disease Treatments Key Players Head office and Products Offered
Table Sickle Cell Disease Treatments Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Sickle Cell Disease Treatments Market Size by Regions 2013-2018 ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size Market Share by Regions 2013-2018
Figure Global Sickle Cell Disease Treatments Market Size Market Share by Regions 2013-2018
Figure Americas Sickle Cell Disease Treatments Market Size 2013-2018 ($ Millions)
Figure APAC Sickle Cell Disease Treatments Market Size 2013-2018 ($ Millions)
Figure Europe Sickle Cell Disease Treatments Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Sickle Cell Disease Treatments Market Size 2013-2018 ($ Millions)
Table Americas Sickle Cell Disease Treatments Market Size by Countries (2013-2018) ($ Millions)
Table Americas Sickle Cell Disease Treatments Market Size Market Share by Countries (2013-2018)
Figure Americas Sickle Cell Disease Treatments Market Size Market Share by Countries in 2017
Table Americas Sickle Cell Disease Treatments Market Size by Type (2013-2018) ($ Millions)
Table Americas Sickle Cell Disease Treatments Market Size Market Share by Type (2013-2018)
Figure Americas Sickle Cell Disease Treatments Market Size Market Share by Type in 2017
Table Americas Sickle Cell Disease Treatments Market Size by Application (2013-2018) ($ Millions)
Table Americas Sickle Cell Disease Treatments Market Size Market Share by Application (2013-2018)
Figure Americas Sickle Cell Disease Treatments Market Size Market Share by Application in 2017
Figure United States Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Canada Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Table APAC Sickle Cell Disease Treatments Market Size by Countries (2013-2018) ($ Millions)
Table APAC Sickle Cell Disease Treatments Market Size Market Share by Countries (2013-2018)
Figure APAC Sickle Cell Disease Treatments Market Size Market Share by Countries in 2017
Table APAC Sickle Cell Disease Treatments Market Size by Type (2013-2018) ($ Millions)
Table APAC Sickle Cell Disease Treatments Market Size Market Share by Type (2013-2018)
Figure APAC Sickle Cell Disease Treatments Market Size Market Share by Type in 2017
Table APAC Sickle Cell Disease Treatments Market Size by Application (2013-2018) ($ Millions)
Table APAC Sickle Cell Disease Treatments Market Size Market Share by Application (2013-2018)
Figure APAC Sickle Cell Disease Treatments Market Size Market Share by Application in 2017
Figure China Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Japan Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Korea Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure India Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Australia Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Table Europe Sickle Cell Disease Treatments Market Size by Countries (2013-2018) ($ Millions)
Table Europe Sickle Cell Disease Treatments Market Size Market Share by Countries (2013-2018)
Figure Europe Sickle Cell Disease Treatments Market Size Market Share by Countries in 2017
Table Europe Sickle Cell Disease Treatments Market Size by Type (2013-2018) ($ Millions)
Table Europe Sickle Cell Disease Treatments Market Size Market Share by Type (2013-2018)
Figure Europe Sickle Cell Disease Treatments Market Size Market Share by Type in 2017
Table Europe Sickle Cell Disease Treatments Market Size by Application (2013-2018) ($ Millions)
Table Europe Sickle Cell Disease Treatments Market Size Market Share by Application (2013-2018)
Figure Europe Sickle Cell Disease Treatments Market Size Market Share by Application in 2017
Figure Germany Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure France Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure UK Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Italy Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Russia Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Spain Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Sickle Cell Disease Treatments Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Sickle Cell Disease Treatments Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Sickle Cell Disease Treatments Market Size Market Share by Countries in 2017
Table Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Sickle Cell Disease Treatments Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Sickle Cell Disease Treatments Market Size Market Share by Type in 2017
Table Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Sickle Cell Disease Treatments Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Sickle Cell Disease Treatments Market Size Market Share by Application in 2017
Figure Egypt Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Israel Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Sickle Cell Disease Treatments Market Size Growth 2013-2018 ($ Millions)
Figure Global Sickle Cell Disease Treatments arket Size Forecast (2018-2023) ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size Market Share Forecast by Regions
Figure Americas Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure APAC Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Europe Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure United States Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Canada Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Mexico Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Brazil Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure China Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Japan Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Korea Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure India Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Australia Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Germany Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure France Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure UK Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Italy Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Russia Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Spain Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Egypt Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure South Africa Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Israel Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure Turkey Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Figure GCC Countries Sickle Cell Disease Treatments Market Size 2018-2023 ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size Market Share Forecast by Type (2018-2023)
Table Global Sickle Cell Disease Treatments Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Sickle Cell Disease Treatments Market Size Market Share Forecast by Application (2018-2023)
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure AstraZeneca Sickle Cell Disease Treatments Market Share (2016-2018)
Table Eli Lilly Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Eli Lilly Sickle Cell Disease Treatments Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Sickle Cell Disease Treatments Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Novartis Sickle Cell Disease Treatments Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Pfizer Sickle Cell Disease Treatments Market Share (2016-2018)
Table Baxter Basic Information, Head Office, Major Market Areas and Its Competitors
Table Baxter Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Baxter Sickle Cell Disease Treatments Market Share (2016-2018)
Table Emmaus Life Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Emmaus Life Sciences Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Emmaus Life Sciences Sickle Cell Disease Treatments Market Share (2016-2018)
Table Bluebird Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bluebird Bio Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Bluebird Bio Sickle Cell Disease Treatments Market Share (2016-2018)
Table Global Blood Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Global Blood Therapeutics Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Global Blood Therapeutics Sickle Cell Disease Treatments Market Share (2016-2018)
Table Sangamo Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sangamo Therapeutics Sickle Cell Disease Treatments Revenue and Gross Margin (2016-2018)
Figure Sangamo Therapeutics Sickle Cell Disease Treatments Market Share (2016-2018)
Table Acceleron Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arena Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors